Report catalogue
The first part is the current situation of the pharmaceutical industry.
Chapter I Operation of Pharmaceutical Industry in China
Section 1 General Operation of Pharmaceutical Industry in China
I. Profits and losses of the pharmaceutical industry in China from 2002 to 2005
Two, 2002-2005 China pharmaceutical industry production and marketing situation.
Three. Benefits of China Pharmaceutical Industry in 2002-2005
Four. China Pharmaceutical Industry Development Index from 2002 to 2005
Section II Economic Comparison of Pharmaceutical Sub-sectors in China
I. Profits and losses of pharmaceutical sub-sectors in China from 2002 to 2005
Two, 2002-2005 China pharmaceutical industry production and marketing situation.
III. From 2002 to 2005, the pharmaceutical industry in China benefited.
IV. China Pharmaceutical Industry Development Index from 2002 to 2005.
Section III Economies of Scale of China Pharmaceutical Industry
I. Profits and losses of pharmaceutical enterprises in China from 2002 to 2005
II. Production and marketing of pharmaceutical enterprises in China from 2002 to 2005.
III. Benefit Status of Pharmaceutical Enterprises in China from 2002 to 2005.
IV. Development Index of Pharmaceutical Enterprises in China from 2002 to 2005.
Section IV Economic Operation of Drug Property Rights in China
I. Economic gains and losses of drug property rights in China from 2002 to 2005
Two, 2002-2005 China pharmaceutical industry economic production and marketing situation.
Third, the economic benefits of pharmaceutical industry in China from 2002 to 2005.
Four, 2002-2005 China pharmaceutical industry economic development index.
Chapter II Characteristics and Investment Environment of Pharmaceutical Investment
Section 1 Research on Investment Characteristics of Pharmaceutical Industry
I. Characteristics of the pharmaceutical industry
Second, the status quo of the pharmaceutical industry
Third, industry concentration analysis
Fourth, the upstream and downstream industrial chain of medicine.
Five, the pharmaceutical industry barriers
Section II Research on Investment and Financing Environment of Pharmaceutical Industry in 2004
I. Industrial policy
Second, the market access conditions
Third, the industry and market management system
Four. Relevant policy environment
Verb (abbreviation of verb) industry reform
The third quarter pharmaceutical industry investment analysis
First, the investment value of each sub-industry
Second, Chinese medicine companies have the most investment value.
Third, the investment value of listed companies.
Four, the five major risks of pharmaceutical investment industry
The third chapter reviews the hot spots of China pharmaceutical industry.
Section 1 GMP certification analysis
I. Impact of GMP certification on the market
Second, attach importance to GMP certification of small and medium-sized pharmaceutical enterprises.
Third, after GMP certification, the overall overcapacity of China's pharmaceutical industry is still intensifying.
Fourth, the marketing trend in the post-GMP certification era
Verb (abbreviation of verb) How will pharmaceutical enterprises consolidate and expand GMP certification results?
Section 2 M&A boom analysis
First, the perspective of pharmaceutical mergers and acquisitions
Second, the motivation, characteristics and trends of pharmaceutical industry restructuring
Third, analysis of the causes and characteristics of M&A wave in China pharmaceutical industry.
Fourthly, the motivation analysis of international pharmaceutical companies' M&A and its enlightenment to China.
V. Pharmaceutical Industry In 2004, M&A reached another climax of restructuring.
6. M&A will become the main theme of the rapid development of the pharmaceutical industry in China.
Seven, the forecast analysis of pharmaceutical industry mergers and acquisitions.
Section III Analysis of Medical Reform
Chapter IV Investment Analysis of Pharmaceutical Industry
The first section overall investment situation
I. Number of new and under construction projects
Second, the distribution of investment projects by industry
Third, the direction of the use of funds
Four. Sources of investment funds
V ownership structure of investors
Completion of intransitive verb investment project
Seven. Analysis of investment benefit and existing problems
Section 2 Analysis of Key Investment Projects
I. Chemical API Enterprise Project
Second, the chemical enterprise project
Third, Chinese medicine enterprise projects
Fourth, medical device enterprise projects
Five, biopharmaceutical enterprise projects
The second part is the global pharmaceutical market analysis.
Chapter V Market Size of the World and Its Major Regions
Section 1 Global Pharmaceutical Market Scale
I. Development of global pharmaceutical market scale from 2002 to 2005
Second, the global pharmaceutical market sales by region in 2002-2005
Three. Ranking and sales of major treatment categories in the world from 2002 to 2005
Four, 2002-2005 global best-selling prescription drug sales and its growth analysis
Five, 200 1 ~ 2002 global top 13 pharmaceutical market sales (by country)
The development trend of new drugs in 2003 and beyond.
Section 2 Analysis of the World OTC Market
First, the overall trend of the transformation from Rx to OTC
Second, the driving force for the transformation from Rx to OTC
Thirdly, the security mechanism of Rx to OTC conversion.
Section III Analysis of the Current Situation of American Pharmaceutical Industry
First, the overall situation of the American pharmaceutical market
Second, the analysis of the current situation of the American pharmaceutical market
Third, modern medicine retail management in the United States
Section 4 Japan
I. General situation of Japanese pharmaceutical market
Second, the production of Chinese herbal medicines in Japan
Third, the internationalization of the Japanese pharmaceutical market.
Section 5 Europe
I. Overview of the European pharmaceutical market
Second, the analysis of the differences between American and European medical management systems
Third, the European pharmaceutical market analysis
Chapter VI Operation Analysis of Global Leading Pharmaceutical Enterprises
Section 1 General Situation Analysis of Leading Pharmaceutical Enterprises in the World
I. Analysis of overall operation from 2003 to 2005
Second, R&D investment analysis
Section II Pfizer's Operation in 2003-2005
I. Total sales in 2003-2005
Two. Sales of main products in 2003-2005
Third, new product development and listing analysis
Fourth, the problems and countermeasures of enterprises
Section III Operation of Roche Pharmaceuticals in 2003-2005
Section IV Operation of Pepsi Squibb from 2003 to 2005
Section V Operation of Novartis Pharmaceuticals in Switzerland from 2003 to 2005
Section VI Operation of Merck Pharmaceuticals in 2003-2005
Section 7 Operation of GlaxoSmithKline in 2003-2005
Section VIII Operation of Nanxing Pharmaceutical in India from 2003 to 2005
Section 9 Operation of Major Biopharmaceutical Companies in the World from 2003 to 2005
Chapter VII Global Pharmaceutical R&D Analysis
Section 1 Global Drug R&D Analysis
First, the analysis of the current situation of medical development research in the world
Second, the main problems encountered in the research of world medical development
Section 2 Global Analysis of Expired and Expired Patented Drugs
Patented drugs whose patents have expired or will expire.
Second, 1998-2007 global best-selling drugs with expired patents
Third, research and development of global antiviral drugs.
Part III Chemical Pharmaceutical Industry
Chapter VIII Chemical Raw Material Medicine Industry
Section 1 General Operation of Chemical Raw Materials
I. Profits and losses of chemical raw material medicine industry from 2002 to 2005
II. Production and marketing of chemical raw materials medicine industry in 2002-2005
Three. Industrial benefit of chemical raw materials in 2002-2005
Four. Development Index of Chemical API Industry in 2002-2005
Section 2 Economies of Scale of Chemical Raw Materials
I. Profits and losses of large, medium and small enterprises of chemical raw materials from 2002 to 2005
Two, 2002-2005, chemical raw materials production and sales enterprises.
Three. Benefits of large, medium and small enterprises of chemical raw materials in 2002-2005
Four. Development index of large, medium and small enterprises of chemical raw materials in 2002-2005
Section 3 Property Right Economy of Chemical Raw Materials
I. Economic gains and losses of property rights of chemical raw materials in 2002-2005
II. Economic production and marketing of chemical raw materials from 2002 to 2005.
III. Economic benefits of chemical raw materials from 2002 to 2005.
IV. Economic development indicators of chemical raw materials in 2002-2005.
The fourth quarter chemical raw material output analysis
I. Output growth in 2002-2005
II. Monthly Changes of Chemical Raw Materials and Drugs in 2004-2005
Three. Production of chemical raw materials in major areas
Section 5 Operation of Chemical Raw Materials in Major Areas
I. General situation
Two. Operation of Chemical Raw Material Medicine Industry in Hebei Province
Three. Operation of Chemical Raw Material Medicine Industry in Zhejiang Province
Four. Operation of Chemical Raw Material Medicine Industry in Shandong Province
Verb (abbreviation of verb) Operation of chemical raw material medicine industry in Heilongjiang Province
Intransitive Verb Operation of Chemical Raw Material Medicine Industry in Jiangsu Province
Seven. Operation of Tianjin Chemical Raw Material Medicine Industry
Section 6 Operation of Leading Enterprises of Chemical Raw Materials
I. Analysis on the Operation of the Top Ten Enterprises of Chemical Raw Materials in 2003-2005
2. Analysis of Top Chemical Raw Materials 100 Enterprises in 2003-2005
Section 7 Foreign Trade of Chemical Raw Materials in China
I. General situation
Two. Imports from 2002 to 2005
Three. Export situation from 2002 to 2005
Fourth, the export of chemical raw materials
Verb (abbreviation of verb) foreign trade policy of chemical raw materials
Chapter IX Operation of Chemical Preparations Industry
Section 1 General Operation of Chemicals
I. Profits and losses of chemical preparation industry from 2002 to 2005
II. Production and Marketing Situation of Chemical Industry in 2002-2005
Three. Benefit of Chemical Industry in 2002-2005
Four. Development Index of Chemical Industry in 2002-2005
Section 2 Economies of Scale of Chemical Preparations
I. Profits and losses of large, medium and small enterprises of chemical preparations in 2002-2005
2. Production and marketing of chemicals in large, medium and small enterprises from 2002 to 2005.
Three. Benefit of chemical preparation enterprises in 2002-2005
IV. Development Index of Chemical Reagent SMEs in 2002-2005
Section 3 Property Right Economy of Chemical Preparations
I. Economic gains and losses of chemical agent property rights in 2002-2005
Two, 2002-2005, the economic production and marketing of chemical preparations.
III. Economic Benefits of Chemical Property Rights from 2002 to 2005
IV. Economic Development Index of Chemical Industry in 2002-2005
The fourth quarter chemical production situation
I. Output growth in 2002-2005
II. Monthly Changes of Chemical Raw Materials and Drugs in 2004-2005
III. Main fields of chemical production
Section 5 Operation of Chemical Agents in Main Fields
I. General situation
Two. Operation of Chemical Preparations Industry in Jiangsu Province
Three. Operation situation of chemical preparation industry in Guangdong
Four. Operation of chemical preparation industry in Shanghai
Verb (abbreviation of verb) Operation of Chemical Industry in Zhejiang Province
VI. Operation of Shaanxi Chemical Industry
Seven. Operation of chemical preparation industry in Beijing
Eight, Shandong chemical operation.
Nine. Operation situation of chemical preparation industry in Henan Province
X. Operation of Sichuan Chemical Industry
Section 6 Operation of Leading Enterprises of Chemical Preparations
I. Operation of Top Ten Chemical Reagent Enterprises in 2003-2005
Two, 2003-2005 100 chemical enterprises.
Section 7 Foreign Trade of Chemical Preparations in China
I. General situation
Two. Imports from 2002 to 2005
Three. Export situation from 2002 to 2005
Fourth, the export of chemical reagents.
Verb (abbreviation of verb) foreign trade policy of chemical preparations
Part IV Traditional Chinese Medicine Industry
Chapter 10 Analysis of Traditional Chinese Medicine Pieces Industry
Section 1 General Operation of Chinese Herbal Pieces
I. Profits and losses of Chinese herbal pieces industry from 2002 to 2005
Two, 2002-2005 Chinese herbal medicine industry production and marketing situation
III. Industrial Benefits of Chinese Herbal Medicine in 2002-2005
Four. Development Index of Chinese Herbal Pieces Industry from 2002 to 2005
Section 2 economies of scale of Chinese herbal pieces
I. Profits and losses of large, medium and small enterprises of Chinese herbal pieces from 2002 to 2005
Two, 2002-2005, the production and sale of Chinese herbal pieces of large, medium and small enterprises.
Three, 2002-2005, Chinese herbal pieces of large, medium and small enterprises benefit.
Four, 2002-2005 Chinese herbal medicine large, medium and small enterprises development indicators
Section 3 Property Right Economy of Chinese Herbal Pieces
I. Economic gains and losses of property rights of Chinese herbal pieces from 2002 to 2005
Two, 2002-2005, the economic production and marketing of Chinese herbal pieces.
Third, the economic benefits of property rights of Chinese herbal pieces in 2002-2005
Four, 2002-2005 Chinese herbal pieces of property rights economic development index
Section 4 Output of Traditional Chinese Medicine Pieces
I. Output growth in 2002-2005
II. Monthly Changes of Chemical Raw Materials and Drugs in 2004-2005
Three, the main areas of Chinese herbal medicine production
Section 5 Operation of Traditional Chinese Medicine Pieces in Key Areas
I. General situation
Second, Guangdong area
Third, Guangxi.
Fourth, Sichuan area.
Verb (abbreviation of verb) Jiangsu area
Sixth, Jilin area.
Seven, Zhejiang area
Section 6 Operation of Leading Enterprises of Traditional Chinese Medicine Pieces
1.2003-2005 analysis of the operation of the top ten Chinese herbal pieces enterprises.
2. Analysis of Top Chinese Herbal Pieces 100 Enterprises in 2003-2005
Chapter III XI Analysis of Chinese Patent Medicine Industry
Section 1 General Operation of Chinese Patent Medicines
I. Profits and losses of Chinese patent medicine industry from 2002 to 2005
II. Production and marketing of Chinese patent medicine industry in 2002-2005
Three. Benefit analysis of Chinese patent medicine industry from 2002 to 2005
IV. Development Index of Chinese Patent Medicine Industry in 2002-2005
Section 2 economies of scale of Chinese patent medicines
I. Profits and losses of Chinese patent medicine enterprises from 2002 to 2005
Two, 2002-2005, Chinese patent medicine production and sales enterprises.
III. Benefit of Chinese patent medicine enterprises from 2002 to 2005.
Four, 2002-2005, large, medium and small enterprises of Chinese patent medicine development index
Section 3 Property Right Economy of Chinese Patent Medicines
I. Economic Profit and Loss of Chinese Patent Medicines in 2002-2005
Two, 2002-2005, the economic production and marketing of Chinese patent medicine.
Third, the economic benefits of Chinese patent medicines from 2002 to 2005.
Four, 2002-2005 proprietary Chinese medicine property rights economic development index
The fourth quarter of Chinese patent medicine output analysis
I. Output growth in 2002-2005
II. Monthly Changes of Chemical Raw Materials and Drugs in 2004-2005
Three, the main areas of Chinese patent medicine production
Section 5 Management of Chinese Patent Medicines in Key Areas
I. General situation
Second, Guangdong area
Third, Jilin area.
Fourth, Jiangxi area.
Verb (abbreviation of verb) Guizhou area
Sixth, Shandong area.
Seven, Sichuan area
Eight, Zhejiang area
Nine, Tianjin area
X. Beijing area
Section 6 Operation of Leading Chinese Patent Medicine Enterprises
I. Analysis on the Operation of Top Ten Chinese Patent Medicine Enterprises from 2003 to 2005
Two, 2003-2005 100 Chinese patent medicine enterprises.
Chapter XII Analysis of Foreign Trade and Advantages and Disadvantages of Traditional Chinese Medicine
Section 1 Import and Export of Traditional Chinese Medicine and Traditional Chinese Medicine
First, Chinese medicine and Chinese herbal medicine export analysis
Two. General situation of import and export of traditional Chinese medicine and Chinese herbal medicine from 2003 to 2005
Section II Analysis of Advantages, Disadvantages and Development Trend of Chinese Medicine Industry
First, the policy analysis of Chinese medicine industry
Second, the technical analysis of Chinese medicine industry
Third, the analysis of the development prospect of Chinese medicine industry
Fourthly, analyze the problems existing in Chinese medicine industry.
Five, the development trend analysis of traditional Chinese medicine industry
Part v biopharmaceutical industry
Chapter XIII World Biopharmaceutical Industry
Section 1 Global biopharmaceutical market size
Section 2 Listed Companies of Global Biotechnology Companies
Section III Development Trend of Global Biopharmaceutical Industry
I. Global projections
Second, the international market sells the best biopharmaceuticals now and in the future.
Three, the recent (since 2002) will be put into production and is developing the best-selling drugs.
Section 4 American biopharmaceutical industry
First, American biotechnology industry rose again in 2003.
Secondly, biotechnology company highly sought after by capital have become upstart.
Section 5 Biomedical Industry in Japan
I. Status of biopharmaceutical industry in Japan
Second, the long-term scale of Japanese biotechnology industry
Third, the achievements of Japanese protein structure.
Section VI Status quo of biopharmaceutical industry in Germany
Section 7 Market Situation of Major Biopharmaceutical Products in the World
First, the overall situation analysis
Second, the world genetic engineering drug industry analysis
Analysis and forecast of global therapeutic protein market in 2002-20 10
Chapter 14 Analysis of biopharmaceutical industry in China
Section 1 General operation of biopharmaceuticals
I. Profits and losses of biopharmaceutical industry in 2002-2005
Production and marketing of biopharmaceutical industry in 2002-2005
Three. Benefits of biopharmaceutical industry in 2002-2005
IV. Development Index of Biopharmaceutical Industry in 2002-2005
Section 2 economies of scale of biopharmaceuticals
I. Profits and losses of large, medium and small biopharmaceutical enterprises from 2002 to 2005
Production and marketing of large, medium and small biopharmaceutical enterprises in 2002-2005.
Three. Benefit of biopharmaceutical enterprises in 2002-2005
Iv. biopharmaceutical development index of large and medium-sized enterprises in 2002-2005
Section 3 biopharmaceutical property rights economy
I. Economic gains and losses of biopharmaceutical property rights in 2002-2005
II. Economic Production and Marketing of Biomedical Industry in 2002-2005
Third, the economic benefits of biopharmaceutical property rights in 2002-2005
IV. Economic development index of biopharmaceutical industry in 2002-2005
Section IV Development of Biomedical Industry in Different Regions
First, regional economic comparison
Second, Hubei biopharmaceutical industry operation analysis
Three, Zhejiang biopharmaceutical industry operation analysis
Four, Shandong biopharmaceutical industry operation analysis
Verb (abbreviation of verb) Analysis on the operation of Shanghai biopharmaceutical industry
Analysis of Guangdong biopharmaceutical industry operation with intransitive verb
VII. Analysis on the operation of biopharmaceutical industry in Beijing.
Eight, Tianjin biopharmaceutical industry operation analysis
Nine, Jiangsu biopharmaceutical industry operation analysis
Chapter 15 China biopharmaceutical market segments
Section 1 Overall Sales Analysis of Main Products
I. Sales of major biopharmaceuticals
Second, the research and development of genetically engineered drugs.
Section II Production and Sales of Interferon in China
First of all, we produce the main types of interferon.
Second, the market space is large.
Third, the competition is becoming more and more fierce.
Fourth, growth takes time.
Five, the current production of interferon listed companies
Section III Vaccine Market
First of all, the vaccine market in China contains huge business opportunities.
Second, the current situation of vaccine production enterprises in China
Third, the market situation of influenza vaccine
Fourth, the hepatitis B vaccine market.
Section 4 Other market segments
I. Human serum albumin
Second, erythropoietin.
Three. interleukin
Fourthly, colony stimulating factor.
Verb (abbreviation for verb) human growth hormone
Sixth, insulin.
Chapter 16 Operation of Leading Biopharmaceutical Enterprises in China
Section 1 Ranking of Biopharmaceutical Leading Enterprises
1. Sales revenue and profit of biopharmaceutical sales revenue top 10 enterprises in 2004
Two, the National Bureau of Statistics in 2004 biopharmaceutical enterprises sales revenue of the top 200 enterprises.
III. The National Bureau of Statistics makes statistics on the top 200 biopharmaceutical enterprises according to their profits.
Four, the State Economic and Trade Commission to monitor the sales revenue and profit of biopharmaceutical enterprises 100 enterprises.
Section II Business Analysis of Biopharmaceutical Listed Enterprises in China
Chapter 17 Analysis of Import and Export of Biological Drugs
Section I Import of Major Biopharmaceutical Products in 2004
Section II Export of Major Biopharmaceutical Products in 2004
I. Total export volume 390
Two. Export countries, quantity and amount of main products
The sixth part is the analysis of medical terminal market.
Chapter 18 Consumer Analysis
Section 1 Basic information of consumers
I. Composition of urban and rural population in various regions of China
Second, the living standards of the people throughout the country.
Section 2 Analysis of Drug Consumption Structure
I. Urban and rural consumption structure
Second, the rural drug market in China
Three, domestic drugs and imported drugs, joint venture drug market share
The third quarter consumer psychology analysis
First, the psychological analysis of consumers buying drugs
Second, consumers' choice of Chinese and western medicines.
Third, the patient's medical habits.
Section 4 Consumers' Standing Medicines
First, there are three major drugs at home.
Second, the purchase channels of standing drugs
Section 5 Changes of Disease Incidence Patterns
I. Changes of global incidence patterns in the 20th century (265-438+0)
Second, the incidence pattern of diseases in China population.
Chapter XIX Current Situation of Sales Channels in Pharmaceutical Market
Section 1 Current Situation of Drug Sales Channels
First, the sales channels and sales models of medicine
Second, the status quo of the pharmaceutical retail industry
Third, the main operators realize the large-scale development of pharmaceutical retail industry.
Fourth, the analysis of pharmaceutical wholesale market
Five, China drug retail meets the challenge.
Section II Current Situation of Medical Services in China
I. Analysis of industrial organization
Second, the status of medical services
Section III Current Situation of Pharmaceutical Chain Operation
I. General situation of pharmaceutical chain operation
Second, the business model of American chain retail pharmacies
Third, the socialization of pharmaceutical chain distribution.
Four, pharmaceutical chain management analysis
Chapter 20 Market segments of main drugs used in hospitals
Section 1 Application of Macrolide Antibiotics in Hospital
I. Overview of main antibiotic types
Second, the market scale of macrolides has grown steadily.
Thirdly, azithromycin, roxithromycin and clarithromycin were outstanding.
Fourth, the development prospect of macrolide antibiotics
Section 2 Analysis on the Sales of Penicillins in Hospitals in China
Analysis of Amoxicillin/Potassium Clavulanate Used in Hospital in the Third Quarter
First, medical drugs-the growth rate has slowed down significantly.
Second, domestic manufacturers-redistribution of market share
Third, market share-the rise of traditional Chinese medicine and the decline of foreign medicine
The fourth quarter vancomycin hospital drug use analysis
First, the total amount of vancomycin used.
Second, the use of vancomycin city
Three. Sales situation of vancomycin production enterprises
Fourth, the proportion of domestic and imported products.
Section V Hospital Market Analysis of β -lactamase Inhibitors
Section VI Analysis on the Use of Cephalosporins
Section 7 Analysis of Key Varieties of Quinolones
I. Levofloxacin
Second, ciprofloxacin.
Three. Ofloxacin
Four. Fleroxacin
Verb (abbreviation of verb) norfloxacin
The intransitive verb gatifloxacin
Section 7 Analysis of the Use of Systemic Hormones in Hospitals
Section 8 Use of Secret Treatment Drugs in Hospitals
Section 9 Digestive System Drug Hospital Market
Section 10 Respiratory Medicine Market
1. Market Trend of Respiratory Drugs in China Hospital in 2002
Second, the hospital market analysis of respiratory drugs
Third, the market situation of the main varieties
Four. Analysis on Retail Market of Respiratory Medicine
V. Market analysis of asthma drugs
Market Analysis of External Skin Drug XI in China in 2003
I. General situation in 2003
Second, the market characteristics
Third, the specific brand analysis
Four. Analysis of market situation in 2002
Section 12 Analysis of Eye Drops Market
Section 13 Market of Plant Alkaloids Antitumor Drugs in Major Cities of China